182 related articles for article (PubMed ID: 29428966)
21. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
22. High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis.
Huang ZL; Lin ZR; Xiao YR; Cao X; Zhu LC; Zeng MS; Zhong Q; Wen ZS
Oncotarget; 2015 Mar; 6(9):6850-61. PubMed ID: 25760075
[TBL] [Abstract][Full Text] [Related]
23. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C
Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
[TBL] [Abstract][Full Text] [Related]
24. RHCG Suppresses Tumorigenicity and Metastasis in Esophageal Squamous Cell Carcinoma via Inhibiting NF-κB Signaling and MMP1 Expression.
Ming XY; Zhang X; Cao TT; Zhang LY; Qi JL; Kam NW; Tang XM; Cui YZ; Zhang BZ; Li Y; Qin YR; Guan XY
Theranostics; 2018; 8(1):185-198. PubMed ID: 29290801
[No Abstract] [Full Text] [Related]
25. Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma.
Yang Z; Cui Y; Ni W; Kim S; Xuan Y
J Cancer Res Clin Oncol; 2017 Feb; 143(2):243-254. PubMed ID: 27680978
[TBL] [Abstract][Full Text] [Related]
26. RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma.
Guo W; Wang C; Guo Y; Shen S; Guo X; Kuang G; Dong Z
Clin Exp Metastasis; 2015 Jan; 32(1):83-98. PubMed ID: 25579665
[TBL] [Abstract][Full Text] [Related]
27. Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
Guo YL; Shan BE; Guo W; Dong ZM; Zhou Z; Shen SP; Guo X; Liang J; Kuang G
J Biomed Sci; 2017 Jan; 24(1):6. PubMed ID: 28077137
[TBL] [Abstract][Full Text] [Related]
28. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
[TBL] [Abstract][Full Text] [Related]
29. Survivin activates NF‑κB p65 via the IKKβ promoter in esophageal squamous cell carcinoma.
Zeng W; Li H; Chen Y; Lv H; Liu L; Ran J; Sun X; Bieerkehazhi S; Liu Y; Li X; Lai W; Watibieke J; Dawulietihan M; Li X; Li H
Mol Med Rep; 2016 Feb; 13(2):1869-80. PubMed ID: 26718331
[TBL] [Abstract][Full Text] [Related]
30. In vivo binding of NF-kappaB to the IkappaBbeta promoter is insufficient for transcriptional activation.
Griffin BD; Moynagh PN
Biochem J; 2006 Nov; 400(1):115-25. PubMed ID: 16792530
[TBL] [Abstract][Full Text] [Related]
31. ING5 inhibits cell proliferation and invasion in esophageal squamous cell carcinoma through regulation of the Akt/NF-κB/MMP-9 signaling pathway.
Zhang GJ; Zhao J; Jiang ML; Zhang LC
Biochem Biophys Res Commun; 2018 Feb; 496(2):387-393. PubMed ID: 29326045
[TBL] [Abstract][Full Text] [Related]
32. Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.
Guo W; Dong Z; Cui J; Guo Y; Shen S; Guo X; Kuang G
Clin Exp Metastasis; 2016 Jan; 33(1):73-85. PubMed ID: 26482475
[TBL] [Abstract][Full Text] [Related]
33. Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2.
Wu Y; Hu L; Liang Y; Li J; Wang K; Chen X; Meng H; Guan X; Yang K; Bai Y
Mol Cancer; 2017 Aug; 16(1):150. PubMed ID: 28854977
[TBL] [Abstract][Full Text] [Related]
34. TRPV6 plays a new role in predicting survival of patients with esophageal squamous cell carcinoma.
Zhang SS; Xie X; Wen J; Luo KJ; Liu QW; Yang H; Hu Y; Fu JH
Diagn Pathol; 2016 Jan; 11():14. PubMed ID: 26818094
[TBL] [Abstract][Full Text] [Related]
35. Msi2 plays a carcinogenic role in esophageal squamous cell carcinoma via regulation of the Wnt/β-catenin and Hedgehog signaling pathways.
Li Z; Jin H; Mao G; Wu L; Guo Q
Exp Cell Res; 2017 Dec; 361(1):170-177. PubMed ID: 29054489
[TBL] [Abstract][Full Text] [Related]
36. Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-κB in esophageal squamous cell carcinoma cells.
Shin WS; Hong Y; Lee HW; Lee ST
Oncotarget; 2016 Nov; 7(45):73242-73256. PubMed ID: 27689325
[TBL] [Abstract][Full Text] [Related]
37. Elevated expression of MDR1 associated with Line-1 hypomethylation in esophageal squamous cell carcinoma.
Zhu J; Ling Y; Xu Y; Lu MZ; Liu YP; Zhang CS
Int J Clin Exp Pathol; 2015; 8(11):14392-400. PubMed ID: 26823755
[TBL] [Abstract][Full Text] [Related]
38. Regulation of Mcl-1 by constitutive activation of NF-κB contributes to cell viability in human esophageal squamous cell carcinoma cells.
Liu H; Yang J; Yuan Y; Xia Z; Chen M; Xie L; Ma X; Wang J; Ouyang S; Wu Q; Yu F; Zhou X; Yang Y; Cao Y; Hu J; Yin B
BMC Cancer; 2014 Feb; 14():98. PubMed ID: 24529193
[TBL] [Abstract][Full Text] [Related]
39.
Gonzaga IM; Soares Lima SC; Nicolau MC; Nicolau-Neto P; da Costa NM; de Almeida Simão T; Hernandez-Vargas H; Herceg Z; Ribeiro Pinto LF
Clin Epigenetics; 2017; 9():130. PubMed ID: 29296124
[TBL] [Abstract][Full Text] [Related]
40. The overexpression of DBC1 in esophageal squamous cell carcinoma correlates with poor prognosis.
Kim SH; Kim JH; Yu EJ; Lee KW; Park CK
Histol Histopathol; 2012 Jan; 27(1):49-58. PubMed ID: 22127596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]